↓ Skip to main content

Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease

Overview of attention for book
Cover of 'Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Introduction and Technical Survey: Protein Aggregation and Fibrillogenesis
  3. Altmetric Badge
    Chapter 2 Fibril Formation by Short Synthetic Peptides
  4. Altmetric Badge
    Chapter 3 In vitro Oligomerization and Fibrillogenesis of Amyloid-beta Peptides
  5. Altmetric Badge
    Chapter 4 Tau Fibrillogenesis
  6. Altmetric Badge
    Chapter 5 Prion Protein Aggregation and Fibrillogenesis In Vitro
  7. Altmetric Badge
    Chapter 6 α-Synuclein Aggregation and Modulating Factors
  8. Altmetric Badge
    Chapter 7 Pathological Self-Aggregation ofb 2 -Microglobulin: A Challenge for Protein Biophysics
  9. Altmetric Badge
    Chapter 8 Islet Amyloid Polypeptide: Aggregation and Fibrillogenesisin vitroand Its Inhibition.
  10. Altmetric Badge
    Chapter 9 Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease
  11. Altmetric Badge
    Chapter 10 Fibrillogenesis of Huntingtin and Other Glutamine Containing Proteins
  12. Altmetric Badge
    Chapter 11 Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease
  13. Altmetric Badge
    Chapter 12 Experimental Inhibition of Peptide Fibrillogenesis by Synthetic Peptides, Carbohydrates and Drugs
  14. Altmetric Badge
    Chapter 13 Experimental Inhibition of Fibrillogenesis and Neurotoxicity by amyloid-beta (Aβ) and Other Disease-Related Peptides/Proteins by Plant Extracts and Herbal Compounds
  15. Altmetric Badge
    Chapter 14 Alzheimer's disease.
  16. Altmetric Badge
    Chapter 15 Modeling the Polyglutamine Aggregation Pathway in Huntington’s Disease: From Basic Studies to Clinical Applications
  17. Altmetric Badge
    Chapter 16 Parkinson’s Disease
  18. Altmetric Badge
    Chapter 17 Human prion diseases: from kuru to variant creutzfeldt-jakob disease.
  19. Altmetric Badge
    Chapter 18 Animal prion diseases.
  20. Altmetric Badge
    Chapter 19 β(2)-Microglobulin Amyloidosis.
  21. Altmetric Badge
    Chapter 20 Systemic AA Amyloidosis
  22. Altmetric Badge
    Chapter 21 Familial amyloidotic polyneuropathy and transthyretin.
  23. Altmetric Badge
    Chapter 22 The Challenge of Systemic Immunoglobulin Light-Chain Amyloidosis (AL)
Attention for Chapter 17: Human prion diseases: from kuru to variant creutzfeldt-jakob disease.
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#47 of 376)
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
9 X users
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Human prion diseases: from kuru to variant creutzfeldt-jakob disease.
Chapter number 17
Book title
Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease
Published in
Sub cellular biochemistry, December 2012
DOI 10.1007/978-94-007-5416-4_17
Pubmed ID
Book ISBNs
978-9-40-075415-7, 978-9-40-075416-4
Authors

Sikorska B, Liberski PP, Beata Sikorska, Pawel P. Liberski, Sikorska, Beata, Liberski, Pawel P.

Abstract

Transmissible spongiform encephalopathies (TSEs) or prion diseases are the names given to the group of fatal neurodegenerative disorders that includes kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker disease (GSS), fatal and sporadic familial insomnia and the novel prion disease variable protease-sensitive prionopathy (PSPr) in humans. Kuru was restricted to natives of the Foré linguistic group in Papua New Guinea and spread by ritualistic endocannibalism. CJD appears as sporadic, familial (genetic or hereditary) and infectious (iatrogenic) forms. Variant CJD is a zoonotic CJD type and of major public health importance, which resulted from transmission from bovine spongiform encephalopathy (BSE) through ingestion of contaminated meat products. GSS is a slowly progressive hereditary autosomal dominant disease and the first human TSE in which a mutation in a gene encoding for prion protein (PrP) was discovered. The rarest human prion disease is fatal insomnia, which may occur, in genetic and sporadic form. More recently a novel prion disease variable protease-sensitive prionopathy (PSPr) was described in humans.TSEs are caused by a still incompletely defined infectious agent known as a "prion" which is widely regarded to be an aggregate of a misfolded isoform (PrP(Sc)) of a normal cellular glycoprotein (PrP(c)). The conversion mechanism of PrP(c) into PrP(Sc) is still not certain.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 2%
Unknown 51 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 25%
Student > Ph. D. Student 8 15%
Researcher 6 12%
Unspecified 3 6%
Professor 3 6%
Other 7 13%
Unknown 12 23%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 21%
Agricultural and Biological Sciences 9 17%
Medicine and Dentistry 7 13%
Nursing and Health Professions 3 6%
Unspecified 3 6%
Other 7 13%
Unknown 12 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2022.
All research outputs
#3,117,104
of 24,486,486 outputs
Outputs from Sub cellular biochemistry
#47
of 376 outputs
Outputs of similar age
#30,531
of 288,095 outputs
Outputs of similar age from Sub cellular biochemistry
#6
of 20 outputs
Altmetric has tracked 24,486,486 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 376 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,095 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.